reference/30901195

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30901195

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review
endingPage	1182
issn	1476-5381 0007-1188
issueIdentifier	5
pageRange	1173-1182
publicationName	British Journal of Pharmacology
startingPage	1173
bibliographicCitation	Brinkmann V. FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system. British J Pharmacology. 2009 Oct 20;158(5):1173–82. doi: 10.1111/j.1476-5381.2009.00451.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5b1250e8987acd1a88d82a98173b69c
date	2009-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/19814729 https://doi.org/10.1111/j.1476-5381.2009.00451.x https://pubmed.ncbi.nlm.nih.gov/PMC2782328
isPartOf	https://portal.issn.org/resource/ISSN/1476-5381 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1895 https://portal.issn.org/resource/ISSN/0007-1188
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system
discusses	http://id.nlm.nih.gov/mesh/M0017742 http://id.nlm.nih.gov/mesh/M0078990 http://id.nlm.nih.gov/mesh/M0020302 http://id.nlm.nih.gov/mesh/M0026976 http://id.nlm.nih.gov/mesh/M0012848 http://id.nlm.nih.gov/mesh/M0254581 http://id.nlm.nih.gov/mesh/M0168077 http://id.nlm.nih.gov/mesh/M0259274
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011409Q000627 http://id.nlm.nih.gov/mesh/D001921Q000187 http://id.nlm.nih.gov/mesh/D013110Q000031 http://id.nlm.nih.gov/mesh/D007107Q000187 http://id.nlm.nih.gov/mesh/D049349Q000037 http://id.nlm.nih.gov/mesh/D009103Q000188 http://id.nlm.nih.gov/mesh/D009103Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068876 http://id.nlm.nih.gov/mesh/D008198Q000473 http://id.nlm.nih.gov/mesh/D004681Q000276 http://id.nlm.nih.gov/mesh/D017853Q000378 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D001253Q000276 http://id.nlm.nih.gov/mesh/D008246Q000502 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D001253Q000473 http://id.nlm.nih.gov/mesh/D004681Q000188 http://id.nlm.nih.gov/mesh/D008198Q000276 http://id.nlm.nih.gov/mesh/D013110Q000502 http://id.nlm.nih.gov/mesh/D017629Q000502 http://id.nlm.nih.gov/mesh/D013110Q000494 http://id.nlm.nih.gov/mesh/D049349Q000502 http://id.nlm.nih.gov/mesh/D049349Q000235 http://id.nlm.nih.gov/mesh/D007249Q000276 http://id.nlm.nih.gov/mesh/D013601Q000502 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013110Q000627 http://id.nlm.nih.gov/mesh/D017853Q000235 http://id.nlm.nih.gov/mesh/D011409Q000494
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.7.1.91 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9908268 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c19ec8043a19854e3b2c015b1301e163 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8532 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107970 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7840 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5354040 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8936 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280335 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5283560 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129060975 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129645792 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128394615

Total number of triples: 76.